文献速递胃肠动力与功能性疾病

评估电话递送认知行为疗法(CBT)与网络递送CBT对比常规治疗在肠易激综合征中的效果(ACTIB):多中心随机试验

Assessing telephone-delivered cognitive-behavioural therapy (CBT) and web-delivered CBT versus treatment as usual in irritable bowel syndrome (ACTIB): a multicentre randomised trial.
PubMed 文献 · Gut · 2019-04-10

本研究为三臂随机对照试验,纳入难治性肠易激综合征成人患者,比较电话递送CBT、网络递送CBT与常规治疗。12个月随访时,两种CBT在IBS症状严重程度评分和工作与社会适应量表上均优于常规治疗,且无严重不良反应。

要点

  • 电话递送CBT在12个月时IBS-SSS较常规治疗降低61.6分(95%CI 33.8-89.5,p<0.001)。
  • 网络递送CBT在12个月时IBS-SSS较常规治疗降低35.2分(95%CI 12.6-57.8,p=0.002)。
  • 两种CBT在WSAS上均优于常规治疗,且所有次要结局显示更大改善(p≤0.002)。

核心结论

  • 两种CBT干预在长达12个月的随访中均优于常规治疗。

研究设计与样本

  • 三臂随机对照试验,评估电话递送CBT、网络递送CBT( minimal therapist support)与常规治疗,参与者与治疗师无法设盲,首席研究者、评估者和统计师设盲。
  • 共筛查1452例,随机558例(38.4%);女性76%,白人91%,平均年龄43岁;391/558(70.1%)完成12个月随访。

主要发现

  • 12个月时,电话递送CBT组IBS-SSS较常规治疗组(205.6分)低61.6分(95%CI 33.8-89.5,p<0.001),网络递送CBT组低35.2分(95%CI 12.6-57.8,p=0.002)。
  • 12个月时,电话递送CBT组WSAS较常规治疗组(10.8分)低3.5分(95%CI 1.9-5.1,p<0.001),网络递送CBT组低3.0分(95%CI 1.3-4.6,p=0.001)。
  • 所有次要结局在CBT组较常规治疗组显示显著更大改善(p≤0.002)。
  • 无严重不良反应。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the clinical effectiveness of two modes of cognitive-behavioural therapy (CBT) for IBS compared with treatment as usual (TAU) in refractory IBS. DESIGN: A three-arm randomised controlled trial assessing telephone-delivered CBT (TCBT), web-based CBT (WCBT) with minimal therapist support, and TAU. Blinding participants and therapists was not possible. Chief investigator, assessors and statisticians were blinded. Participants were adults with refractory IBS (clinically significant symptoms for ≥12 months despite first-line therapies), recruited by letter and opportunistically from 74 general practices and three gastroenterology centres in London and South of England between May 2014 to March 2016. Co-primary outcomes were IBS Symptom Severity Score (IBS-SSS) and Work and Social Adjustment Scale (WSAS) at 12 months. RESULTS: 558/1452 (38.4%) patients screened for eligibility were randomised: 76% female: 91% white: mean age 43 years. (391/558) 70.1% completed 12 months of follow-up. Primary outcomes: Compared with TAU (IBS-SSS 205.6 at 12 months), IBS-SSS was 61.6 (95% CI 33.8 to 89.5) points lower (p<0.001) in TCBT and 35.2 (95% CI 12.6 to 57.8) points lower (p=0.002) in WCBT at 12 months. Compared with TAU (WSAS score 10.8 at 12 months) WSAS was 3.5 (95% CI 1.9 to 5.1) points lower (p<0.001) in TCBT and 3.0 (95% CI 1.3 to 4.6) points lower (p=0.001) in WCBT. All secondary outcomes showed significantly greater improvement (p≤0.002) in CBT arms compared with TAU. There were no serious adverse reactions to treatment. CONCLUSION: Both CBT interventions were superior to TAU up to 12 months of follow-up. TRIAL REGISTRATION NUMBER: ISRCTN44427879.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Everitt HA, Landau S, O'Reilly G, et al. Assessing telephone-delivered cognitive-behavioural therapy (CBT) and web-delivered CBT versus treatment as usual in irritable bowel syndrome (ACTIB): a multicentre randomised trial. Gut. 2019. PMID: 30971419. doi:10.1136/gutjnl-2018-317805

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。